To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD
Clinical trial NCT03404466 · COMPLETED
Trial details
- NCT number
- NCT03404466
- Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-24
- Primary completion
- 2018-07-10
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.